Kiniksa Pharmaceuticals Q1 2026 Earnings EPS Surprises by 315 Despite Stock Decline ADPT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise CYTK Q1 2026 Earnings Narrower Loss Boosts Investor Confidence but Stock Falters Token Cat Limited TC Q3 2021 Earnings WiderThanExpected Loss Highlights Operational Challenges CLIR Q1 2026 Earnings WiderThanExpected Loss Highlights PreRevenue Challenges BURU Q3 2023 Earnings PreRevenue Loss of 014 per Share as Strategic Developments Underway